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ABSTRACT The 90-kDa heat shock protein (HSP90) of eukaryotes is a highly abun-
dant and essential chaperone required for the maturation of regulatory and signal
proteins. In the protozoan parasite Leishmania donovani, causative agent of the fatal
visceral leishmaniasis, HSP90 activity is essential for cell proliferation and survival.
Even more importantly, its inhibition causes life cycle progression from the insect
stage to the pathogenic, mammalian stage. To unravel the molecular impact of
HSP90 activity on the parasites’ gene expression, we performed a ribosome proﬁling
analysis of L. donovani, comparing genome-wide protein synthesis patterns in the
presence and absence of the HSP90-speciﬁc inhibitor radicicol and an ectopically ex-
pressed radicicol-resistant HSP90 variant. We ﬁnd that ribosome-protected RNA faith-
fully maps open reading frames and represents 97% of the annotated protein-
coding genes of L. donovani. Protein synthesis was found to correlate poorly with
RNA steady-state levels, indicating a regulated translation as primary mechanism for
HSP90-dependent gene expression. The results conﬁrm inhibitory effects of HSP90
on the synthesis of Leishmania proteins that are associated with the pathogenic, in-
tracellular stage of the parasite. Those include heat shock proteins, redox enzymes,
virulence-enhancing surface proteins, proteolytic pathways, and a complete set of
histones. Conversely, HSP90 promotes fatty acid synthesis enzymes. Complementing
radicicol treatment with the radicicol-resistant HSP90rr variant revealed important
off-target radicicol effects that control a large number of the above-listed proteins.
Leishmania lacks gene-speciﬁc transcription regulation and relies on regulated
translation instead. Our ribosome footprinting analysis demonstrates a control-
ling function of HSP90 in stage-speciﬁc protein synthesis but also signiﬁcant,
HSP90-independent effects of the inhibitor radicicol.
IMPORTANCE Leishmania parasites cause severe illness in humans and animals.
They exist in two developmental stages, insect form and mammalian form, which
differ in shape and gene expression. By mapping and quantifying RNA fragments
protected by protein synthesis complexes, we determined the rates of protein syn-
thesis for 90% of all Leishmania proteins in response to the inhibition of a key reg-
ulatory protein, the 90-kDa heat shock protein. We ﬁnd that Leishmania depends on
a regulation of protein synthesis for controlling its gene expression and that heat
shock protein 90 inhibition can trigger the developmental program from insect form
to mammalian form of the pathogen.
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All living organisms express a group of proteins known as heat shock proteins (HSPs)that function as molecular chaperones, assisting newly synthesized, translocated,
or stress-damaged proteins in attaining their native and functional state and preventing
the harmful intracellular aggregation of proteins. Apart from this well-established role,
heat shock proteins are increasingly identiﬁed as part of regulatory pathways. In
eukaryotes, the 90-kDa class of HSPs (HSP90), assisted by a wide array of chaperones
and cochaperones, is well known to affect cellular differentiation, gene expression
control, and signal transduction pathways. The over 200 client proteins identiﬁed to
date include signal transduction protein kinases, nuclear receptors, promoter- and
enhancer-binding transcription factors, and cytoskeletal proteins (1–5). HSP90 is also
involved in the regulation of its own synthesis by its interaction with heat shock
transcription factor (6, 7).
Nonpathogenic and pathogenic microorganisms also depend on HSP90 for differ-
entiation and cell cycle control. In Saccharomyces cerevisiae, 10 to 20% of the proteome
is under HSP90-dependent control (5, 8). In the malaria-causing parasite Plasmodium
falciparum, HSP90 is essential for growth and development in human blood cells (9–11).
Similar ﬁndings were reported for the related apicomplexan parasite Toxoplasma gondii
(12) and for the gut parasite Entamoeba histolytica (13). HSP90 is also essential in
Leishmania donovani, the causative agent of the lethal kala-azar fever, a.k.a. visceral
leishmaniasis, where it was shown to be essential for proliferation and intracellular,
parasitic persistence (14, 15).
The genus Leishmania is transmitted by phlebotomine sandﬂies to a broad range of
vertebrates, including canines, rodents, and humans. The parasites reside in macro-
phages and other cells of the reticuloendothelial system, where they multiply within
parasitophorous vacuoles that are derived from phagosomes (16–18). This mammalian
parasite stage, the amastigote, differs from the insect stage, the promastigote, not only
morphologically but also metabolically (19–21), since the transmission from a poikilo-
thermic arthropod host to a homeothermic mammalian host requires the parasites to
adapt to elevated temperatures, an acidic milieu, and alternative carbon sources.
Classic cis-regulatory gene promoter and enhancer elements are absent from the
Leishmania genome. In addition, Leishmania genes are organized in multigene, unidi-
rectional transcription units (22), giving rise to multicistronic mRNA precursors which
are processed into monocistronic mRNAs by coupled transsplicing and polyadenylation
(23). Combined, these ﬁndings rule out a control of individual genes at the level of
transcription (24–26), pointing at RNA stability (27–29) and translation control (30, 31)
as regulated steps of gene expression. Yet, correlation between the steady-state levels
of mRNAs and their corresponding proteins is only between 20 and 40% (32), arguing
against RNA processing and/or stability as the dominating control mechanisms. Al-
though lacking inducible transcription, the leishmaniae respond to elevated tempera-
ture and other stresses with the increased synthesis of HSPs (30, 31).
The Leishmania HSP families comprise members that are expressed constitutively
during both life cycle stages, e.g., HSP70 and HSP90 (30), and others whose expression
increases during the conversion into the amastigote stage (21, 33, 34). The in vitro
conversion from elongated, ﬂagellated L. donovani promastigotes to ovoid, aﬂagellated,
so-called axenic amastigotes can be achieved by the elevation of the culture temperature
to 37°C and the acidiﬁcation of the growth medium (35). The same morphological differ-
entiation can be observed when L. donovani is treated with the HSP90-speciﬁc inhibitors
geldanamycin (GA) or radicicol (RAD), which both target the special ATPase domain of
HSP90 chaperones. These parasites also show an amastigote-like morphology and an
increased expression of the amastigote-speciﬁc A2 protein family (14). This points to a
central role for HSP90 in the parasite’s life cycle and stage conversion. In Leishmania,
HSP90 (synonymously called HSP83) is encoded by multiple tandemly arranged gene
copies (27, 36), and is a highly abundant, constitutively expressed protein in Leishmania
spp. (30). It interacts with chaperones such as HSP70 and various cochaperones to form
so-called foldosome complexes (37). Both GA and RAD bind HSP90 and inhibit its
ATPase domain, thereby abrogating foldosome activity and causing cell growth arrest
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(38). A single amino acid exchange in the ATP-binding pocket of HSP90 can abrogate
the RAD-mediated inhibition. This was ﬁrst observed in the RAD-producing fungus
Humicola fuscoatra (39) and correlated with an isoleucine residue in place of a highly
conserved leucine. Exchange of the corresponding Leu33 against Ile in the L. donovani
HSP90 and overexpression of this transgene prevent RAD-induced growth arrest and
RAD-triggered amastigote differentiation (15), completely reversing the effects of
HSP90 inhibition. However, a putative endoplasmic reticulum-speciﬁc HSP90 family
member, GRP94 (40), and the supposed mitochondrial Trap1/HSP75 chaperone (41, 42)
both contain ATPase domains that are homologous to that of HSP90 and may also be
targeted by ATP competitors.
To analyze stage-speciﬁc gene expression at the relevant level, i.e., protein synthesis
and abundance, proteome comparisons have been used, producing insight into the
changes incurred by the parasite during stage conversion. A detailed analysis of the
proteomic changes in the course of axenic, temperature-induced promastigote-to-
amastigote conversion (21) conﬁrmed earlier assessments for single proteins but also
showed a “retooling of metabolic pathways” occurring during the differentiation. L.
donovani undergoes a shift from carbohydrate metabolism pathways in the insect host
to using fatty acids and amino acids as carbon sources while residing intracellularly in
the mammalian host, reﬂecting the changing availability of nutrients. In spite of their
advantages, such as detection of posttranslational modiﬁcations, comparative pro-
teomics have limitations. Mass spectrometric detection of peptides requires high-
picomolar quantities and is biased toward ionizable peptides, reducing the overall
detection to 20% of the hypothetical proteome, even with advanced technologies
(43).
Ribosome proﬁling is a new technique related to the DNase footprint assay (44) and
able to ﬁll the knowledge gap between RNA abundance and proteome analysis. It was
developed by Ingolia et al. (45) and is based on the deep sequencing of ribosome-
protected mRNA fragments. The comparison of the deep sequencing data from
ribosome-protected mRNA fragments and the total mRNA from a cell allows distin-
guishing mRNA that is actively translated at a given time point in the cell, but also the
translation efﬁciency, i.e., the number of ribosome-protected RNA fragments for each
given mRNA. This facilitates quantiﬁcation of nascent protein synthesis and identiﬁca-
tion of new and unusual open reading frames (ORFs) or short regulatory upstream ORFs
(uORFs) in the untranslated regions (46, 47). This is of high importance for the study of
organisms whose gene expression control relies on posttranscriptional events only, e.g.,
the Trypanosomatida (29). Ribosome proﬁling was used to unravel the stage conversion
pathways in Trypanosoma cruzi (48), T. brucei (49, 50), and Toxoplasma gondii (51). In the
second study, ribosome proﬁling also revealed new coding sequences that had es-
caped previous, algorithm-based detection and annotation. Since small proteins often
escape detection by mass spectrometry due to not yielding enough peptides for
identiﬁcation, ribosome proﬁling can detect expression of short ORFs more sensitively.
In this paper, we applied ribosome proﬁling to monitor the changes in the protein
synthesis induced by HSP90 inhibition of L. donovani parasites. HSP90 activity or the
lack thereof affects the synthesis of several chaperone proteins, but also of histones,
amastins, proteolytic proteins, and redox enzymes. We also ﬁnd evidence that the
HSP90 inhibitor radicicol has signiﬁcant off-target effects, i.e., non-HSP90-speciﬁc ef-
fects, that modulate the synthesis of proteins. We ﬁnd that the observed changes of
protein synthesis do not correlate with changes in RNA abundance, conﬁrming earlier
ﬁndings obtained by RNA arrays and comparative proteomics (32).
RESULTS
Ribosome footprints faithfully map open reading frames of L. infantum. The
ﬁrst aim of our study was to assess the accuracy of ribosome proﬁling for Leishmania
promastigotes. For this we used three different promastigote populations: (i) wild-type
L. donovani in the absence (WT-RAD) and (ii) presence (WTRAD) of RAD at its IC80, and
(iii) the RAD-resistant strain L. donovani [Hsp90rr] (15) in the presence of RAD
Radicicol-Induced Proteins in Leishmania
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(HSP90rrRAD) (Fig. 1A). As expected, in vitro growth of WTRAD is reduced by 75%
compared with WT-RAD, whereas HSP90rrRAD shows a 35% growth reduction,
conﬁrming that HSP90rr confers RAD resistance (see Fig. S1 in the supplemental
material).
FIG 1 Experimental setup. (A) Schematic representation of biological samples used in the analysis
showing (i) HSP90 able to bind ATP (orange), (ii) HSP90 bound by RAD, and (iii) HSP90rr able to bind ATP,
no binding of RAD. N, N-terminal domain; M, middle domain; C, C-terminal domain. (B) Flow chart of
ribosome proﬁling analysis.
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Parasites from those populations were collected and treated with cycloheximide
and heparin to arrest ribosomes in situ. Cells were then lysed, and the lysates were split
equally for (i) isolation of total mRNA or (ii) RNase treatment followed by monoribo-
some puriﬁcation using a sucrose density gradient centrifugation and a UV-light
absorbance-based fractionation (Fig. S2). The protected RNA (ribosome footprints) was
extracted from the monosomes while the total mRNA was chemically fragmented
according to established protocols to yield ribosome footprint-comparable fragments
(50, 52, 53). Nucleic acid fragments from both fractions were then processed for
next-generation sequencing. Resulting sequence reads were then aligned to the L.
infantum reference genome, which is 99% identical to the L. donovani genome, but
offers better coverage and annotations. We used the RiboTaper analysis pipeline (54) to
map the genome-wide distribution of protected sites (P sites), a.k.a. ribosome footprints
(RFPs) (Fig. 1B) and to quantify P site alignments to coding sequences (CDSs). The latter
were used as a measure of the translation rate of a CDS.
Of the 98 million reads obtained from the three samples, 32.5 million reads
aligned to the L. infantum protein coding sequences, with 59.7 million reads aligning to
rRNA sequences. Of the 8,237 protein coding sequences identiﬁed in the L. infantum
genome, 97% and 99% were represented by RFP reads and RNA reads, respectively
(Table S1). The RNA-Seq and P site alignment per CDS as raw and normalized values, as
well as the calculated translation efﬁciency (TE) values calculated, are shown in Table S2
(WT-RAD), Table S3 (WTRAD), and Table S4 (HSP90rrRAD).
Figure 2A shows RFPs (purple) aligning accurately to three annotated CDSs for
ribosomal proteins on chromosome 21 while the coverage by RNA-Seq reads (gray)
extends into the putative UTRs. Furthermore, the RFPs show the expected 3-bp
periodicity (Fig. 2B and C), reﬂecting the 3-nt increments of ribosome translocation
during translation and thus supporting the notion that the RNase-protected fragments
are indeed the result of a ribosome footprint. Such periodicity is not observed with the
transcriptome-derived reads (Fig. 2B and C).
Several short upstream open reading frames (uORFs) in the 5= UTRs of genes (55–57)
could also be identiﬁed in Leishmania by visual inspection of RFP read patterns. A
systematic search was not possible due to the lack of UTR data in the available genome
annotation. One interesting example is the gene for heat shock protein 100 (HSP100)
on chromosome 29 (LinJ29.1360, Fig. 3A). While the transcriptome-derived reads cover
the 5= and 3= untranslated regions (UTRs) (Fig. 3B) that were determined previously (33,
58), RFPs map to the annotated ORF (Fig. 3C) starting 13 nt upstream of the predicted
start codon (Fig. 3E). In addition, RFP reads also show alignment to a 30-bp region
found 425 nt upstream of the HSP100 start codon. This 30-bp footprint starts 12 nt
upstream of an AUG codon (Fig. 3D), with an in-frame termination codon located 45 nt
downstream, and can thus be considered a uORF, possibly regulating heat shock-
induced translation of HSP100 (31, 33). The putative uORF is in a different reading frame
than the HSP100-coding sequence.
We also observed instances of false gene annotation, e.g., the gene for translation
initiation factor 4E-4 (LinJ.30.0460) is annotated to the region from position 150087 to
149161 on chromosome 30, encoding a 308-aa polypeptide. Our data (Fig. 3F) suggest
that LinJ.30.0460 translation initiates 420 nucleotides upstream, at position 150507, and
rather encodes a 448-aa protein. Indeed, this is conﬁrmed by the annotation of the L.
donovani BPK282A1 genome. Freire et al. also assumed a missing N terminus in the
annotation of LmjEIF4E4 after sequence comparison with the T. brucei orthologue (59).
From our data we conclude that the RFPs faithfully represent the translatome of L.
donovani.
Gene regulation in Leishmania. We next calculated the changes of ribosome
footprinting (RFP) density, RNA abundance (RNA), and translation efﬁciency (TE) in-
duced by challenge with radicicol (RAD) in the presence or absence of RAD-resistant
HSP90rr, using the data in Table S2, Table S3, and Table S4. We used the RiboTaper
analysis tool to obtain the RFP and RNA read densities for all 8,240 genes. Of these, 283
Radicicol-Induced Proteins in Leishmania
November/December 2018 Volume 3 Issue 6 e00214-18 msystems.asm.org 5
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
genes were eliminated due to lack of aligned reads in any of the 6 data sets (not
shown). RFP and RNA read counts were normalized using the median counts per CDS
for each sample (Table S1). RFP and RNA counts were then log2-transformed.
We then determined the coefﬁcient of determination (R2) between the ΔRFP (vari-
ation of ribosome footprinting densities) and the ΔRNA (variation of RNA abundance).
FIG 2 Veriﬁcation of ribosome footprints. (A) Read mapping analysis of RNA-Seq (gray) and RFPs (purple)
on a cluster of three ribosomal protein-coding genes on chromosome 21. Blue arrows delineate
annotated coding sequences with gene IDs. Read alignment densities for RNA-Seq (top panel) and RFP
(bottom panel) are depicted. (B and C) The 30-nt ribosome footprints (black bars) of the representative
sample HSP90rrRAD were mapped to the annotated CDSs in relation to the initiation (B) and
termination (C) sites and plotted by the ﬁrst nucleotides of the P-sites. Corresponding RNA-Seq reads are
shown as blue peaks. Note that peak densities occur at 3-nt intervals for RFPs, representing 3-nt
increments of ribosome movement.
Bifeld et al.
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FIG 3 Identiﬁcation of uORFs and extended coding sequences. (A) Position of the HSP100 CDS on chromosome
29; ruler shows position in kilobase pairs. (B) RNA-Seq read alignment at the HSP100 gene locus. (C) RFP read
alignment at the HSP100 gene locus. (D) Enlargement of the 5= UTR of HSP100 showing RFPs aligned to an
(Continued on next page)
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This was performed for WTRAD versus WT-RAD (overall RAD effects), WTRAD versus
HSP90rrRAD (on-target RAD effects), and HSP90rrRAD versus WT-RAD (off-target
RAD effects) and for 7,957 genes (Fig. 4A to C; Table S5). R2 values for ΔRNA versus ΔRFP
are close to zero, meaning that the RNA abundance does not determine protein
synthesis rates as measured by ribosome footprinting. We conclude that RAD-induced
gene expression changes must be regulated at the translation level.
We next compared the overall ΔRFP values (WTRAD versus WT-RAD) with either
the on-target ΔRFP (WTRAD versus HSP90rrRAD, Fig. 4D) or the off-target ΔRFP
(HSP90rrRAD versus WT-RAD, Fig. 4E) and determined the coefﬁcient of determina-
tion, R2. Both plots suggested an intermediate degree of correlation of R2  0.21 and
R2  0.34, respectively. This indicates that overall RAD effects on protein synthesis are
more likely due to off-target inhibition by RAD than to HSP90-speciﬁc, on-target
activity, raising the question on which targets other than HSP90 (HSP83) RAD may be
active.
RAD-induced protein synthesis changes. Using the same RiboTaper analysis data
(Table S5), we next identiﬁed proteins that are induced or reduced 2-fold under RAD
treatment (Table S6), and from these we grouped proteins by function (Table 1;
Table S7).
FIG 3 Legend (Continued)
upstream AUG codon, representing a putative uORF. (E) Zoom into the translation initiation site of HSP100
represented by RFP reads aligning 12 nucleotides upstream of the AUG start codon. The blue bar represents the
start of the HSP100 CDS. (F) Possible erroneous annotation of the LinJ.30.0460 (eIF4-E4) CDS, with RFP reads
aligning well upstream of the annotated AUG start codon. Annotated and experimentally determined CDSs are
shown as arrows.
FIG 4 Correlation analysis. ΔRFP was plotted against ΔRNA for (A) WTRAD/WT-RAD, (B) WTRAD/HSP90rrRAD,
and (C) HSP90rrRAD/WT-RAD. The coefﬁcients of determination, R2, are displayed. (D) Plot of overall ΔRFP
(WTRAD/WT-RAD) against on-target ΔRFP (WTRAD/HSP90rrRAD) with coefﬁcient of determination, R2. (E) Plot
of overall ΔRFP (WTRAD/WT-RAD) against off-target ΔRFP (HSP90rrRAD/WT-RAD) with coefﬁcient of determi-
nation, R2.
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TABLE 1 List of induced proteins by functional groupsa
Category and gene ID Annotation
WTRAD vs WT-RAD
RFP RNA TE
Protein folding/chaperones
LinJ.22.0670 A2 protein 2.873 0.576 2.297
LinJ.33.0940 DnaJ, putative 1.169 0.241 1.410
LinJ.27.2350 DnaJ, putative 1.059 0.550 0.509
LinJ.25.2290 DnaJ/zinc-ﬁnger double-stranded RNA-binding, putative 1.064 0.813 0.250
LinJ.29.1360 HSP100 0.674 0.301 0.373
LinJ.34.0230 HSP23 1.086 0.495 1.581
LinJ.28.3040 HSP70, putative 1.024 0.328 1.352
LinJ.33.0350 HSP90 1.601 0.372 1.230
LinJ.30.2480 mtHSP70 1.535 0.321 1.215
LinJ.04.0710 Tir chaperone protein (CesT) family 1.076 0.431 1.507
LinJ.36.2190 TPR repeat, putative 1.027 0.607 0.420
LinJ.26.0360 TPR repeat, putative 1.078 0.000 1.078
LinJ.05.0410 TPR repeat, putative 1.160 0.677 0.483
Redox enzymes
LinJ.32.2880 As/Sb reductase, putative 1.256 0.919 2.175
LinJ.34.0070 Ascorbate peroxidase, putative 1.845 0.481 1.363
LinJ.31.2600 Ferredoxin, 2Fe-2S-like protein 0.934 0.122 0.813
LinJ.27.0670 Glutaredoxin-like protein 1.396 0.241 1.637
LinJ.26.0770 Glutathione peroxidase-like protein, putative 2.512 0.576 1.936
LinJ.26.0780 Glutathione peroxidase-like protein, putative 1.274 0.582 0.692
LinJ.32.1910 Iron superoxide dismutase, putative 1.275 0.010 1.265
LinJ.23.0500 Trypanothione synthetase, putative 1.207 0.060 1.268
LinJ.29.1250 Tryparedoxin 1 1.170 0.430 0.740
LinJ.15.1140 Tryparedoxin peroxidase 1.120 0.235 0.885
LinJ.15.1100 Tryparedoxin peroxidase 1.029 0.406 0.623
Proteolytic enzymes
LinJ.26.2720 CAAX prenyl protease 2, putative 1.270 0.122 1.148
LinJ.14.0920 Calpain-like cysteine peptidase, putative 2.157 0.247 1.910
LinJ.20.1210 Calpain-like cysteine peptidase, putative 1.067 0.045 1.023
LinJ.36.6520 Carboxypeptidase, putative 1.700 0.177 1.523
LinJ.14.0180 Carboxypeptidase, putative 1.051 0.339 0.712
LinJ.22.1540 Metallopeptidase, clan MA(E), family M3, putative, partial 1.746 0.475 2.222
LinJ.36.4230 Metallopeptidase, clan MC, family M14, putative 1.022 0.268 0.754
LinJ.09.1360 PPPDE putative peptidase domain-containing protein, putative 1.369 0.530 1.900
LinJ.34.4390 Proteasome beta 7 subunit, putative 2.134 0.610 2.745
LinJ.01.0730 Ubiquitin-activating enzyme, putative 1.050 0.129 1.179
LinJ.28.0500 Ubiquitin-activating enzyme, putative 1.348 1.345 0.003
LinJ.36.4580 Ubiquitin protein ligase, putative (fragment) 1.256 0.134 1.390
LinJ.32.0730 Ubiquitin-conjugating enzyme E2, putative 1.099 0.759 0.340
LinJ.21.0500 Ubiquitin-conjugating enzyme-like protein 1.026 0.278 0.747
LinJ.31.1930 Ubiquitin-fusion protein 2.716 0.889 1.826
LinJ.13.0620 Ubiquitin-like protein 1.185 0.145 1.040
Amastin family
LinJ.30.1490 Ama1 protein, putative 1.256 0.521 1.777
LinJ.08.0650 Amastin surface glycoprotein, putative 1.058 0.421 0.637
LinJ.08.0780 Amastin-like protein 2.157 1.218 0.938
LinJ.08.0680 Amastin-like protein 2.104 0.122 1.983
LinJ.34.1040 Amastin-like protein 2.078 0.374 1.704
LinJ.29.1450 Amastin-like protein 1.513 0.806 0.706
LinJ.08.0760 Amastin-like protein 1.034 0.759 0.275
LinJ.24.1300 Amastin-like surface protein-like protein 2.597 0.589 3.186
LinJ.34.1680 Amastin-like surface protein, putative 2.303 0.241 2.544
LinJ.34.1010 Amastin-like surface protein, putative 1.809 0.566 1.242
LinJ.34.1020 Amastin-like surface protein, putative 1.527 0.264 1.263
LinJ.34.1690 Amastin-like surface protein, putative 1.349 0.978 2.327
LinJ.34.1730 Amastin-like surface protein, putative 1.031 0.185 0.845
LinJ.34.1150 Amastin-like surface protein, putative 1.015 0.396 0.619
LinJ.29.3010 Amastin, putative 4.303 0.049 4.255
LinJ.29.3030 Amastin, putative 2.283 0.555 1.727
LinJ.31.0460 Amastin, putative 1.443 0.213 1.230
LinJ.29.3000 Amastin, putative 1.157 0.174 0.983
(Continued on next page)
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We ﬁrst looked at protein folding catalysators, i.e., chaperones and other heat shock
proteins. Surprisingly, only a few heat shock proteins, i.e., HSP90, HSP70, mtHSP70, and
HSP23, show induced synthesis under heat stress. This induction is not abrogated by
overexpression of the RAD-resistant HSP90rr, indicating an induction via off-target RAD
effects. The A2 protein, a stress protein correlated with promastigote-to-amastigote
differentiation (60), shows the strongest induction, in keeping with the observed
pro-amastigote effect of RAD (14, 15). This induction appears to be mediated by
inactivation of HSP90 since the effect is abrogated by HSP90rr expression.
RAD treatment also induces a number of redox enzymes implicated in the oxidative
stress response, among them members of the glutathione and trypanothione path-
TABLE 1 (Continued)
Category and gene ID Annotation
WTRAD vs WT-RAD
RFP RNA TE
Chromatin proteins
LinJ.20.0460 Cell cycle checkpoint protein RAD1-like, putative (fragment) 1.481 0.978 0.503
LinJ.28.2550 DNA replication licensing factor MCM6, putative 1.098 1.148 0.050
LinJ.09.0930 Histone H1-like protein 1.041 0.280 0.761
LinJ.09.0930 Histone H1-like protein 1.041 0.280 0.761
LinJ.27.1120 Histone H1, putative 1.387 0.377 1.011
LinJ.27.1070 Histone H1, putative 1.040 0.096 0.944
LinJ.27.1120 Histone H1, putative 1.387 0.377 1.011
LinJ.27.1070 Histone H1, putative 1.040 0.096 0.944
LinJ.29.1850 Histone H2A, putative 5.007 1.081 3.927
LinJ.29.1870 Histone H2A, putative 2.050 0.759 2.809
LinJ.29.1850 Histone H2A, putative 5.007 1.081 3.927
LinJ.29.1870 Histone H2A, putative 2.050 0.759 2.809
LinJ.19.0040 Histone H2B 2.688 0.796 3.484
LinJ.09.1410 Histone H2B 1.532 0.493 2.025
LinJ.19.0040 Histone H2B 2.688 0.796 3.484
LinJ.09.1410 Histone H2B 1.532 0.493 2.025
LinJ.16.0600 Histone H3, putative 1.240 0.505 1.744
LinJ.16.0600 Histone H3, putative 1.240 0.505 1.744
LinJ.36.0020 Histone H4 1.443 1.328 2.771
LinJ.15.0010 Histone H4 1.034 0.210 1.245
LinJ.35.0020 Histone H4, putative, pseudogene 1.204 0.108 1.313
LinJ.30.1010 Histone-binding protein RBBP4, putative 1.388 1.463 0.076
LinJ.26.0710 Regulator of chromosome condensation (RCC1) repeat, putative 1.671 0.189 1.860
Protein kinases
LinJ.27.1680 Casein kinase I-like protein 2.651 0.022 2.673
LinJ.29.2260 Cdc2-related kinase 10, putative 1.231 0.039 1.191
LinJ.33.1930 Dual-speciﬁcity protein kinase, putative 1.993 0.929 1.064
LinJ.35.4060 Protein kinase A catalytic subunit isoform 1 1.335 0.185 1.149
LinJ.32.1350 Protein kinase domain-containing protein, putative 1.619 0.039 1.580
LinJ.32.1350 Protein kinase domain-containing protein, putative 1.619 0.039 1.580
LinJ.29.0380 Protein kinase-like protein 1.267 0.921 0.346
LinJ.17.0440 Protein kinase, putative 2.207 0.451 1.756
LinJ.35.4690 Protein kinase, putative 1.256 1.700 2.957
LinJ.14.1510 Protein kinase, putative 1.050 0.633 0.416
LinJ.19.0590 Protein kinase, putative 1.191 0.300 0.891
LinJ.19.1510 Protein kinase, putative 1.329 0.344 1.673
LinJ.19.1640 Protein kinase, putative 1.651 1.241 0.410
LinJ.28.3240 Serine/threonine kinase, putative 1.157 0.978 2.135
Fatty acid metabolism
LinJ.14.0770 Fatty acid elongase, putative 1.934 0.826 2.760
LinJ.14.0710 Fatty acid elongase, putative 1.083 0.027 1.109
LinJ.14.0720 Fatty acid elongase, putative 1.124 0.344 1.468
LinJ.14.0750 Fatty acid elongase, putative 1.236 0.241 0.995
LinJ.14.0670 Fatty acid elongase, putative 1.622 0.149 1.771
LinJ.01.0520 Fatty acyl-CoA synthetase 2, putative 1.918 0.794 1.124
LinJ.03.0220 Long-chain fatty acyl-CoA synthetase, putative 1.482 0.241 1.241
LinJ.01.0540 Long-chain-fatty acid-CoA ligase, putative 1.663 0.014 1.650
aPositive numbers indicate log2 increases, while negative numbers indicate log2 decreases.
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ways. This is in keeping with the need of amastigotes to adapt to the oxidative
environment of macrophage lysosomes. RAD treatment also upregulates the synthesis
of proteolytic enzymes, such as various peptidases and ubiquitin tagging pathways,
reﬂecting the need for proteolytic degradation during the cellular differentiation from
promastigotes to amastigotes.
Surface proteins of the amastin family are known surface markers of the amastigote
stage (61). Our analysis shows 18 amastin family members with a more-than-2-fold
increase of synthesis under RAD treatment, with the majority activated through off-
target RAD effects. This further supports the correlation between RAD treatment and
differentiation toward the amastigote stage.
The synthesis of most histones is increased under RAD treatment by a combination
of HSP90-speciﬁc and off-target RAD effects. This indicates an increased need for
nucleosomal packing of DNA under RAD challenge, either mimicking a feature of
amastigotes or reﬂecting the growth arrest caused by HSP90 inhibition (14, 15).
The effect of RAD on ribosomal protein and translation factor synthesis is ambigu-
ous, with roughly the same number of proteins showing increased or reduced synthe-
sis. This may reﬂect the observed reprogramming of translation during RAD treatment.
We also observe mostly increased synthesis of several known or putative protein
kinases. None of the kinases we found affected by RAD treatment has been ascribed a
role in the stress response or in stage conversion.
A functional group of proteins that are largely negatively affected by RAD treatment
comprises enzymes of the fatty acid synthesis, possibly reﬂecting a reported shift to
fatty acid catabolism for amastigotes (21). This is further underscored by a gene
ID-based metabolic pathway analysis (not shown) which also identiﬁes fatty acid
metabolic pathways as negatively affected. This may reﬂect the metabolic changes
during promastigote-to-amastigote differentiation. These negative effects are mostly
due to HSP90-speciﬁc RAD effects.
DISCUSSION
In most eukaryota and prokaryota, the expression of speciﬁc genes or operons is
controlled at the level of RNA synthesis and RNA processing, allowing an approximate
quantitative assessment of gene expression patterns by analyzing the steady-state level
of gene-speciﬁc mRNAs. However, control of gene expression is also exerted indepen-
dently of RNA abundance, at the levels of translation initiation and elongation (62). This
is even more important in Leishmania spp., where no gene-speciﬁc transcription
regulation exists (25) and where the correlation of transcriptome and proteome is poor
(32, 63). In contrast, translatome data—obtained by ribosome proﬁling—correlate well
with proteome data (45, 48), even reﬂecting the subunit stoichiometry of multiprotein
complexes (64). Thus, ribosome proﬁling provides a reliable option for the quantiﬁca-
tion of translation across the transcriptome, which is especially useful for trypanoso-
matids as these parasites rely on posttranscriptional control of gene expression (65).
Our ribosome proﬁling analysis indeed provides a representative view of L. donovani
gene expression. An average of 33% of the qualiﬁed reads aligned to annotated open
reading frames (see Table S1 in the supplemental material), a value that compares well
with the earlier reported 16% for Saccharomyces cerevisiae (45). We also found 97%
of the annotated CDS in the L. donovani genome represented by the RFP reads (not
shown). RNA-Seq reads show a similarly high coverage at 99%, with 30% of the
qualiﬁed reads mapping to CDS. This lower value reﬂects the absence of untranslated
regions (UTRs) from the database we used for alignment.
Ribosomes are macromolecules with the A, P, and E decoding sites (66), resulting in
a 3-nt periodicity of movement along the mRNA molecule. This is reﬂected in our
results by the observed 3-nt periodicity of the RFP read alignments (Fig. 2B and C).
Because the ribosome occupies 26 to 30 bases on the mRNA molecule, with an AUG or
a stop codon in the P-site, the coverage with RFP reads should start approximately 12
nucleotides upstream of the start codon (AUG) and end 18 nucleotides upstream of
the stop codon, which is indeed reﬂected in our results (Fig. 2B and C). Thus, the
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coverage by RFP reads displays the actively translated mRNA sequences in L. donovani.
Moreover, the unusual genome organization of trypanosomatids may lead to incorrect
annotations by using standard algorithms for the ORF identiﬁcation, which may be
corrected by RFP densities. This was shown for T. brucei (50) and for L. donovani, e.g.,
for the gene LinJ.30.0460 (Fig. 3F).
Due to their peculiar transcription and maturation of mRNA, trypanosomatids rely
on posttranscriptional regulation for their adaptation to environmental changes. Post-
transcriptional regulation in eukaryotes often depends on cis-acting elements in the
mRNA 5= UTR, such as internal ribosomal entry sites (IRESs), which allow a cap-
independent translation initiation (56, 67), or short open reading frames upstream of
the protein-coding sequence (uORFs), which have regulatory capacities (55–57). In
trypanosomatids, the translation regulation is commonly accepted as being directed by
elements located in the 3= UTR (65, 68). However, the 5= UTR of the L. mexicana HSP83
(HSP90) gene was shown to be crucial for the translation initiation of the CDS (68),
demonstrating the regulatory function of an as-yet-unidentiﬁed cis-acting element.
Moreover, uORFs were found in L. mexicana mRNAs by transcriptome analysis (69) as
well as in T. brucei by applying ribosome proﬁling (49, 50). We applied RiboTaper (54)
to our ribosome proﬁling-derived raw data, which identiﬁed annotated CDSs but no
uORFs (not shown), due to the lack of UTR sequences in the available genome
annotation. However, by manual inspection of the RFP read densities on genes subject
to stage-speciﬁc expression control, we were able to identify at least one uORF located
upstream of the HSP100 gene (LinJ.29.1360) (Fig. 3C), which starts 12 nt upstream of an
initiation codon and contains an in-frame termination codon (Fig. 3D). uORFs initiate
with either an AUG or a non-AUG start codon, terminate with in-frame stop codons
(70–72), and are considered translation-reducing elements, as they capture some of the
scanning preinitiation complexes (55, 57). However, uORFs also promote translation of
particular mRNAs under cell stress conditions (57, 70, 73), and non-AUG uORFs are
found in the 5= UTRs of a variety of chaperones (74). Thus, the identiﬁed ribosome-
protected sequence upstream of the HSP100 ORF (Fig. 3D) is likely an uORF and may
serve as a regulatory element for translation in L. donovani. In keeping with this
hypothesis, HSP100 expression is indeed temperature induced (33).
For the longest time, the Leishmania HSP90 was inaccessible to genetic analysis due
to its high number of identical, tandemly repeated gene copies (27, 36) and the
essential nature of this major chaperone. The availability of the HSP90-speciﬁc inhibi-
tors geldanamycin and RAD allowed a ﬁrst assessment of the importance of HSP90 for
the parasites’ life cycle control and their stage-speciﬁc gene expression (14, 75). This
was then augmented by the use of an inhibitor-resistant, phenotypically neutral variant
of HSP90, HSP90rr (15), which allows monitoring of the phenotypic effects of point
mutants in a conditional setting. This also conﬁrmed that the effects of the HSP90
inhibitor RAD on the morphology were due to the RAD-HSP90 interaction. In this
context, dosage is of critical importance. High concentrations of geldanamycin cause a
growth arrest in the G2 cell cycle phase (14). HSP90 inhibitors, e.g., the antitumor drug
candidate 17-AAG, a derivative of geldanamycin, may even ﬁnd a use as antileishmanial
therapeutics, having activity against cutanotropic leishmaniae both in vitro (76) and in
vivo (77). Those ﬁndings are in keeping with our observation that intracellular leish-
maniae depend on HSP90 function (15).
Earlier work (14, 15) indicated that the majority of the effects of geldanamycin and
RAD can be attributed to HSP90 inhibition. In the light of our ﬁndings, this view must
be reconsidered. The availability of the RAD-resistant HSP90rr transgene allowed us to
differentiate between target-speciﬁc effects due to HSP90 inhibition which were absent
under ectopic HSP90rr expression and effects of RAD in the HSP90rr-expressing cells
that were absent from the untreated WT-RAD samples and that we consider off-target.
This result was unexpected since previous work showed that ectopic HSP90rr expres-
sion reverted all phenotypic effects of RAD treatment in promastigotes and intracellular
amastigotes (15).
Since RAD interacts speciﬁcally with the nucleotide binding sites of HSP90 chaper-
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one family members, but not with those of other ATP-hydrolyzing chaperones (78), we
suspect that the off-target interactions of RAD inhibition in Leishmania are with two
other HSP90 paralogues, namely, GRP94/LPG3 (40) and/or HSP75/TRAP-1 (41). While
the former has been described as essential for L. donovani lipophosphoglycan synthesis
(40, 79), the latter is part of the protein payload of immunomodulatory Leishmania
exosomes and dependent on HSP100 for its exosomal localization (42). While HSP90
synthesis is increased via HSP90 inhibition, neither GRP94/LPG3 nor TRAP-1/HSP75 is
induced under RAD inhibition (Table S5). Both GRP94 and TRAP-1 chaperones are
known to bind RAD with HSP90-like afﬁnity (78, 80, 81).
The Leu33 residue of HSP90 is conserved in GRP94 and in TRAP-1 (Fig. 5). It may be
interesting to express variants of GRP94 and TRAP-1 with an equivalent Leu60Ile and
Leu29Ile exchange, respectively, to see which of them may counteract the off-target
(OT) effects of RAD. Such knowledge would be important, since several proteins of
importance are controlled via the pathway(s) affected by the OT effects. Nevertheless,
RAD may also target another protein(s) in Leishmania that has so far escaped identiﬁ-
cation as potential targets.
It is noteworthy that GRP94/lpg3 null mutants are viable in vitro but entirely lack
synthesis of lipophosphoglycans (40), important surface molecules that promote Leish-
mania survival early in the infection. It will therefore be interesting to see whether the
negative effects of RAD on the in vitro infectivity (15) may be due to inactivation of
GRP94.
RAD treatment causes changes in the synthesis of several groups of proteins. It was
shown before that the abundance of heat shock proteins HSP90, HSP70, and HSP100
and also of the amastigote-speciﬁc A2 proteins increases under supposed HSP90
inhibition (14). Indeed, synthesis of these proteins increases between 1.6-fold and
7.5-fold under RAD treatment. Other notable heat shock proteins in this group are
HSP23, a major facilitator of thermotolerance in Leishmania (34), and the mitochondrial
HSP70. The other examples in this group are putative chaperones due to structural
features.
The synthesis of 12 redox proteins is also induced under RAD, three by target-
speciﬁc regulation and three by off-target effects, with the rest showing a mixture of
both. The proteins of this group belong to the oxidative stress protection pathways of
the parasites that facilitate the survival of amastigotes in the host macrophages. For
instance, ascorbate peroxidase was shown to protect Leishmania against oxidative
stress-induced apoptosis (82). Trypanothione synthase and trypanothione have been
linked to antimony resistance and viability (83, 84).
Under conditions of cell stress, damaged proteins must be recognized and directed
to proteolytic degradation in the proteasome. This is facilitated by binding to heat
shock proteins and conjugation with ubiquitin. Seven members of the ubiquitin
pathway and one proteasome subunit are induced under RAD-simulated cell stress.
Moreover, a number of peptidases are also synthesized at higher rates, possibly
reﬂecting the need for proteolytic activity during the size reduction of the parasite
when it converts from the longish promastigote to the ovoid amastigote, one of the
phenotypic effects of RAD.
No fewer than 18 members of the amastin surface proteins are found to be
synthesized at increased rates. Amastins are a large family of transmembrane surface
proteins, expressed predominantly in the amastigote stage (28, 61), that are linked to
Leishmania donovani tropism (85) and intracellular survival of L. braziliensis (86). Their
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LinJ.33.0370: ---------------------------MTETFAFQAEINQLMSLIINTFYSNKEIFLRELISNASDACDKIRYQSLTDPS - HSP90 
LinJ.29.0790: MANSSLLRVVLVALLLLGSVTVSAGDGRGTPIAFQAEVSKMLDILVNSLYTNRAVFLRELISNGSDALDKIRVLYLTSPK - GRP94 
LinJ.33.2520: -------------------------------MGFKTETRQLLDIVACSLYSDKEVFIRELVSNASDALEKRHLLELSNPD - TRAP-1
FIG 5 Sequence alignment of HSP90 chaperone family members in L. infantum. MUSCLE alignment of the deduced N-terminal amino acid
sequences of 3 HSP90 paralogues, with the conserved Leu residues of HSP90 indicated by an arrow.
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upregulation, mostly by presumed off-target activity of RAD, is further indication that
RAD treatment activates amastigote-speciﬁc gene expression beyond heat shock and
other stress proteins.
The upregulation of multiple histone proteins under RAD indicates a higher nucleo-
some density under RAD. However, a detailed proteome study showed no evidence of
increased histone protein abundance in in vitro-differentiated amastigotes (21).
Inhibition of HSP90 also has a negative impact on the fatty acid synthesis, in keeping
with the changes of metabolic pathways observed by proteome analysis of axenically
cultivated amastigotes (21).
The inhibition of HSP90 triggers multiple changes in the gene expression of Leish-
mania, suggesting an inhibitory effect of this major chaperone on the expression of
several stress-induced genes. In parallel, RAD also appears to have an effect on the
protein synthesis patterns via off-target interactions, possibly with other HSP90 family
chaperones. Still, a natural modulation of HSP90 activity may be one way leading to life
cycle stage-speciﬁc gene expression in a protozoan that completely lacks control of
individual gene transcription and that regulates gene expression independently of
mRNA steady-state levels (32; this paper). Such natural modulation pathways may
include protein kinases, since it was shown that HSP90 and several associated chap-
erones and cochaperones are the subjects of amastigote stage-speciﬁc protein phos-
phorylation (87). The recent ﬁnding that HSP90 and HSP70 are both substrates for MAP
kinase 1 (88) supports this idea, since MAP kinase 1 or LmxMPK1 is crucial for the
intracellular survival of Leishmania (89). Another kinase recently shown (A. Hombach-
Barrigah, K. Bartsch, D. Smirlis, H. Rosenqvist, A. MacDonald, F. Dingli, D. Loew, G. F.
Späth, N. Rachidi, M. Wiese, and J. Clos, unpublished data) to catalyze HSP90 phos-
phorylation is casein kinase 1.2 (90, 91), which is crucial for promastigote growth (92)
and is also found in the HSP90-containing exosome-like vesicles that are shed by
Leishmania as a means for host cell immune modulation (42, 93). Neither kinase is
upregulated upon HSP90 inhibition (Table S5). One may speculate that stage-speciﬁc
roles played by protein kinases are transduced through reversible modulation of HSP90
activity. Once protein kinases and their target sites on HSP90 are unraveled, the
availability of HSP90 phosphorylation site mutations (A. Hombach, unpublished data)
combined with the power of ribosome proﬁling analysis can be expected to test this
hypothesis.
MATERIALS AND METHODS
Leishmania cell culture. Promastigote L. donovani strain 1SR (MHOM/SD/62/1SR) was cultured at
25°C in growth medium based on Medium 199 (Sigma-Aldrich) supplemented with 25% heat-inactivated
FCS, 40 mM HEPES, pH 7.4, 0.2% NaHCO3, 100 M adenine, 1.2 g ml1 6-biopterin, 10 g ml1 heme,
and 1 Pen/Strep/L-glutamine (Sigma), pH 7.0. Strain L. donovani [HSP90rr] (15) was maintained under
G418 selection (100 g/ml) until 24 h before exposure to radicicol.
Leishmania cell harvest and lysis. The parasites were counted using a CASY cell counter (Roche)
and added at a cell density of 4 106 ml1 into 150 ml of growth medium containing 5 ng ml1 RAD
(Sigma). The parasites were allowed to proliferate for 72 h at 25°C. The further protocol was adapted from
reference 52. Brieﬂy, cycloheximide (Sigma) was added to the parasite cultures at a ﬁnal concentration
of 100 g ml1 and incubated for 5 min at room temperature. Three biological samples with an average
cell count of 1 109 each were collected by centrifugation at 3,000  g and 4°C for 5 min, washed once
by resuspension in 1 ml polysome lysis buffer (15 mM Tris-HCl, pH 7.4, 0.3 M KCl, 5 mM MgCl2, 0.5 mM
DTT, 100 g ml1 cycloheximide, and 1 mg ml1 heparin), and pelleted at 3,000  g and 4°C for 5 min.
The supernatant was discarded. The cells were transferred to 1.5-ml microcentrifuge tubes using 1 ml of
ice-cold polysome lysis buffer and pelleted again at 10,000  g and 4°C for 40 s. The cells were lysed by
adding 400 l polysome lysis buffer containing 1% Triton X-100 and 10 units of Turbo DNase I (Ambion)
followed by incubation on ice for 30 min. The RNA concentrations of the cell lysates was determined at
OD260 using a NanoDrop 2000 (Thermo Fisher Scientiﬁc).
Preparation of the sequencing libraries and footprinting of RNA and mRNA. The sequencing
libraries were prepared as described previously (50).
Brieﬂy, for the puriﬁcation of ribosome footprint RNAs, the polysomes in the cell lysates were
disjoined to monosomes by digesting away unprotected RNA. Aliquots of 200 l (OD260  50) were
treated with 1,600 U of RNase I (Ambion) and incubated on ice for 1 h. The RNA digestion was stopped
by adding 100 U of RNasin RNase inhibitor (Promega) to the aliquots. For the undigested control, 100 U
of RNasin RNase inhibitor was added to RNase I-untreated aliquots of each sample. The RNase I-treated
samples were loaded onto a sucrose gradient (10% [wt/vol] to 50% [wt/vol]) as described in Ingolia et
Bifeld et al.
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al. (45). Gradients were fractionated on the Gradient Station (Science Services) based on their absorbance
at A254. Fractions representing the monosome peak were collected at 50-mm distance starting at 0.05
A254 absorbance.
Footprint RNA from the monosome fraction and total RNA from the undigested cell fraction were
puriﬁed by a hot (65°C) acid phenol-chloroform-isoamyl alcohol (vol/vol/vol, 25:24:1) extraction as
described by Ingolia (94).
The mRNA isolation from the total RNA fraction and the following mRNA fragmentation were
performed as described by Vasquez et al. (50). Brieﬂy, total RNA was subjected to poly(A) enrichment
using a Dynabeads mRNA puriﬁcation kit (Ambion) followed by an incubation with RNA fragmentation
reagent (Ambion). A 15% polyacrylamide gel puriﬁcation was performed for the size selection (26 to
34 nt) of footprint RNA and fragmented mRNA in comparison with two synthetic RNA markers (IDT
[Integrated DNA Technology]).
The mRNA and ribosome footprint sequencing libraries were generated following the protocol of
Ingolia et al. (53), except the rRNA depletion steps (steps 47 to 54), which were discarded, and the last
ampliﬁcation step (step 55) was performed using the 2 Kapa HiFi Hot Start Mix (Kapa Biosystems).
Libraries were then sequenced using an Illumina NextSeq 500 system.
Preprocessing and mapping of reads. For the RiboTaper pipeline (54), cutadapt (95) and Bowtie
(96) were used to clip adapters and ﬁlter rRNA reads, respectively. Thereafter, the STAR aligner (97) was
used to map remaining reads to the genome and the resulting alignment ﬁles were sorted and indexed
using SAMtools (98). The create_metaplots.bash script from the RiboTaper pipeline was used to generate
site coverage plots. The RiboTaper script was then started with appropriate read and cutoff parameters.
Alignments of RFP reads and RNA-Seq reads were imported and graphically displayed using the
Assemble module of the MacVector software suite and imported into the Intaglio vector graphics
software for ﬁgure assembly.
To correct for variables due to library preparation efﬁciency, we normalized the number of protected
sites (P-sites) and RNA reads per coding sequence (CDS), respectively, using the median number of reads
per CDS for each sample. The translation efﬁciency (TE) was then calculated from those median-
normalized read numbers (TE  P-sites/RNA sites).
To determine changes to protein synthesis, RNA abundance, and translation efﬁciency, we performed
pairwise comparison of P-sites/CDS (RFP  ribosome footprints), RNA sites/CDS (RNA), and TE (Table S5).
Data availability. All raw sequencing reads were deposited at the NCBI Sequence Read Archive (SRA)
under the project no. PRJNA495919.
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Supplemental material for this article may be found at https://doi.org/10.1128/
mSystems.00214-18.
FIG S1, PDF ﬁle, 0.05 MB.
FIG S2, PDF ﬁle, 0.5 MB.
TABLE S1, XLSX ﬁle, 0.01 MB.
TABLE S2, XLS ﬁle, 1.9 MB.
TABLE S3, XLS ﬁle, 1.9 MB.
TABLE S4, XLS ﬁle, 1.8 MB.
TABLE S5, XLS ﬁle, 1.8 MB.
TABLE S6, XLS ﬁle, 0.2 MB.
TABLE S7, XLS ﬁle, 0.04 MB.
ACKNOWLEDGMENTS
We thank Antje Hombach for critical input and materials and the members of our
labs for help, advice and constructive criticism. We also thank Amelia Kraus and Carolin
Wedel for high-throughput sequencing of the libraries.
The work described here was funded in part by the Deutsche Forschungsgemein-
schaft (grant CL120/8-1). E.B. was supported by the European Union’s Seventh Frame-
work Programme for research, technological development and demonstration under
grant agreement no. 603240 (NMTrypI—New Medicine for Trypanosomatidic Infec-
tions; http://www.nmtrypi.eu/) and by a grant from the German Centre for Infection
Research (DZIF). T.N.S. was funded by a Young Investigator Program of the Research
Center for Infectious Diseases (ZINF) of the University of Wu¨rzburg and The German
Research Foundation DFG (grant SI 1610/3-1).
Author contributions were as follows: E.B., concept of study, ribosome preparation,
library construction (with J-J.V.), data analysis and interpretation, manuscript prepara-
tion; S.L., RiboTaper analysis, bioinformatic analyses; K.B., Leishmania cultivation and
treatment, data analysis; J-J.V., ribosome preparation, library construction (with E.B.);
T.N.S., conception and supervision; J.C., conception, supervision, data analysis and
Radicicol-Induced Proteins in Leishmania
November/December 2018 Volume 3 Issue 6 e00214-18 msystems.asm.org 15
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
interpretation, manuscript preparation. All authors read and approved the ﬁnal man-
uscript.
The authors declare that they are unaware of any conﬂict of interest in the context
of this work.
REFERENCES
1. Rutherford SL, Zuker CS. 1994. Protein folding and the regulation of
signaling pathways. Cell 79:1129–1132. https://doi.org/10.1016/0092
-8674(94)90003-5.
2. Scheibel T, Buchner J. 1998. The Hsp90 complex—a super-chaperone
machine as a novel drug target. Biochem Pharmacol 56:675–682.
https://doi.org/10.1016/S0006-2952(98)00120-8.
3. Richter K, Buchner J. 2001. Hsp90: chaperoning signal transduction. J
Cell Physiol 188:281–290. https://doi.org/10.1002/jcp.1131.
4. Pratt WB, Toft DO. 2003. Regulation of signaling protein function and
trafﬁcking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med
(Maywood) 228:111–133. https://doi.org/10.1177/153537020322800201.
5. Taipale M, Jarosz DF, Lindquist S. 2010. HSP90 at the hub of protein
homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11:
515–528. https://doi.org/10.1038/nrm2918.
6. Morimoto RI. 1998. Regulation of the heat shock transcriptional
response: cross talk between a family of heat shock factors, molecular
chaperones, and negative regulators. Genes Dev 12:3788–3796. https://
doi.org/10.1101/gad.12.24.3788.
7. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R. 1998. Repression of
heat shock transcription factor HSF1 activation by HSP90 (HSP90 com-
plex) that forms a stress-sensitive complex with HSF1. Cell 94:471–480.
https://doi.org/10.1016/S0092-8674(00)81588-3.
8. Zhao R, Houry WA. 2007. Molecular interaction network of the Hsp90
chaperone system. Adv Exp Med Biol 594:27–36. https://doi.org/10
.1007/978-0-387-39975-1_3.
9. Banumathy G, Singh V, Pavithra SR, Tatu U. 2003. Heat shock protein
90 function is essential for Plasmodium falciparum growth in human
erythrocytes. J Biol Chem 278:18336–18345. https://doi.org/10.1074/
jbc.M211309200.
10. Kumar R, Musiyenko A, Barik S. 2003. The heat shock protein 90 of
Plasmodium falciparum and antimalarial activity of its inhibitor, geldana-
mycin. Malar J 2:30. https://doi.org/10.1186/1475-2875-2-30.
11. Shonhai A, Maier AG, Przyborski JM, Blatch GL. 2011. Intracellular pro-
tozoan parasites of humans: the role of molecular chaperones in devel-
opment and pathogenesis. Protein Pept Lett 18:143–157. https://doi
.org/10.2174/092986611794475002.
12. Ahn HJ, Kim S, Nam HW. 2003. Molecular cloning of the 82-kDa heat
shock protein (HSP90) of Toxoplasma gondii associated with the entry
into and growth in host cells. Biochem Biophys Res Commun 311:
654–659. https://doi.org/10.1016/j.bbrc.2003.10.045.
13. Singh M, Sharma S, Bhattacharya A, Tatu U. 2015. Heat shock protein 90
regulates encystation in Entamoeba. Front Microbiol 6:1125. https://doi
.org/10.3389/fmicb.2015.01125.
14. Wiesgigl M, Clos J. 2001. Heat shock protein 90 homeostasis controls
stage differentiation in Leishmania donovani. Mol Biol Cell 12:3307–3316.
https://doi.org/10.1091/mbc.12.11.3307.
15. Hombach A, Ommen G, Chrobak M, Clos J. 2013. The Hsp90-Sti1 inter-
action is critical for Leishmania donovani proliferation in both life cycle
stages. Cell Microbiol 15:585–600. https://doi.org/10.1111/cmi.12057.
16. Antoine JC, Prina E, Lang T, Courret N. 1998. The biogenesis and prop-
erties of the parasitophorous vacuoles that harbour Leishmania in mu-
rine macrophages. Trends Microbiol 6:392–401. https://doi.org/10.1016/
S0966-842X(98)01324-9.
17. Courret N, Frehel C, Gouhier N, Pouchelet M, Prina E, Roux P, Antoine JC.
2002. Biogenesis of Leishmania-harbouring parasitophorous vacuoles
following phagocytosis of the metacyclic promastigote or amastigote
stages of the parasites. J Cell Sci 115:2303–2316.
18. Real F, Mortara RA. 2012. The diverse and dynamic nature of Leishmania
parasitophorous vacuoles studied by multidimensional imaging. PLoS
Negl Trop Dis 6:e1518. https://doi.org/10.1371/journal.pntd.0001518.
19. Ralton JE, Naderer T, Piraino HL, Bashtannyk TA, Callaghan JM, McCon-
ville MJ. 2003. Evidence that intracellular beta1-2 mannan is a virulence
factor in Leishmania parasites. J Biol Chem 278:40757–40763. https://
doi.org/10.1074/jbc.M307660200.
20. Paape D, Lippuner C, Schmid M, Ackermann R, Barrios-Llerena ME,
Zimny-Arndt U, Brinkmann V, Arndt B, Pleissner KP, Jungblut PR, Aebi-
scher T. 2008. Transgenic, ﬂuorescent Leishmania mexicana allow direct
analysis of the proteome of intracellular amastigotes. Mol Cell Proteom-
ics 7:1688–1701. https://doi.org/10.1074/mcp.M700343-MCP200.
21. Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein
D. 2008. Retooling Leishmania metabolism: from sand ﬂy gut to
human macrophage. FASEB J 22:590–602. https://doi.org/10.1096/fj
.07-9254com.
22. Myler PJ, Beverley SM, Cruz AK, Dobson DE, Ivens AC, McDonagh PD,
Madhubala R, Martinez-Calvillo S, Ruiz JC, Saxena A, Sisk E, Sunkin SM,
Worthey E, Yan S, Stuart KD. 2001. The Leishmania genome project: new
insights into gene organization and function. Med Microbiol Immunol
190:9–12. https://doi.org/10.1007/s004300100070.
23. LeBowitz JH, Smith HQ, Rusche L, Beverley SM. 1993. Coupling of poly(A)
site selection and trans-splicing in Leishmania. Genes Dev 7:996–1007.
https://doi.org/10.1101/gad.7.6.996.
24. Myler PJ, Sisk E, McDonagh PD, Martinez-Calvillo S, Schnaufer A, Sunkin
SM, Yan S, Madhubala R, Ivens A, Stuart K. 2000. Genomic organization
and gene function in Leishmania. Biochem Soc Trans 28:527–531.
https://doi.org/10.1042/bst0280527.
25. Clayton CE. 2002. Life without transcriptional control? From ﬂy to man
and back again. EMBO J 21:1881–1888. https://doi.org/10.1093/emboj/
21.8.1881.
26. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M,
Sisk E, Rajandream M-A, Adlem E, Aert R, Anupama A, Apostolou Z,
Attipoe P, Bason N, Bauser C, Beck A, Beverley SM, Bianchettin G, Borzym
K, Bothe G, Bruschi CV, Collins M, Cadag E, Ciarloni L, Clayton C, Coulson
RMR, Cronin A, Cruz AK, Davies RM, De Gaudenzi J, Dobson DE, Duester-
hoeft A, Fazelina G, Fosker N, Frasch AC, Fraser A, Fuchs M, Gabel C,
Goble A, Goffeau A, Harris D, Hertz-Fowler C, Hilbert H, Horn D, Huang
Y, Klages S, Knights A, Kube M, Larke N, Litvin L, Lord A, Louie T, Marra
M, Masuy D, Matthews K, Michaeli S, Mottram JC, Müller-Auer S, Munden
H, Nelson S, Norbertczak H, Oliver K, O’Neil S, Pentony M, Pohl TM, Price
C, Purnelle B, Quail MA, Rabbinowitsch E, Reinhardt R, Rieger M, Rinta J,
Robben J, Robertson L, Ruiz JC, Rutter S, Saunders D, Schäfer M, Schein
J, Schwartz DC, Seeger K, Seyler A, Sharp S, Shin H, Sivam D, Squares R,
Squares S, Tosato V, Vogt C, Volckaert G, Wambutt R, Warren T,
Wedler H, Woodward J, Zhou S, Zimmermann W, Smith DF, Blackwell
JM, Stuart KD, Barrell B, Myler PJ. 2005. The genome of the kineto-
plastid parasite, Leishmania major. Science 309:436–442. https://doi
.org/10.1126/science.1112680.
27. Shapira M, Zilka A, Garlapati S, Dahan E, Dahan I, Yavesky V. 2001. Post
transcriptional control of gene expression in Leishmania. Med Microbiol
Immunol 190:23–26. https://doi.org/10.1007/s004300100073.
28. Rochette A, McNicoll F, Girard J, Breton M, Leblanc E, Bergeron MG,
Papadopoulou B. 2005. Characterization and developmental gene reg-
ulation of a large gene family encoding amastin surface proteins in
Leishmania spp. Mol Biochem Parasitol 140:205–220. https://doi.org/10
.1016/j.molbiopara.2005.01.006.
29. Haile S, Papadopoulou B. 2007. Developmental regulation of gene ex-
pression in trypanosomatid parasitic protozoa. Curr Opin Microbiol 10:
569–577. https://doi.org/10.1016/j.mib.2007.10.001.
30. Brandau S, Dresel A, Clos J. 1995. High constitutive levels of heat-shock
proteins in human-pathogenic parasites of the genus Leishmania.
Biochem J 310:225–232. https://doi.org/10.1042/bj3100225.
31. Clos J, Brandau S, Hoyer C. 1998. Chemical stress does not induce heat
shock protein synthesis in Leishmania donovani. Protist 149:167–172.
https://doi.org/10.1016/S1434-4610(98)70021-5.
32. Lahav T, Sivam D, Volpin H, Ronen M, Tsigankov P, Green A, Holland N,
Kuzyk M, Borchers C, Zilberstein D, Myler PJ. 2011. Multiple levels of
gene regulation mediate differentiation of the intracellular pathogen
Leishmania. FASEB J 25:515–525. https://doi.org/10.1096/fj.10-157529.
33. Krobitsch S, Brandau S, Hoyer C, Schmetz C, Hübel A, Clos J. 1998.
Leishmania donovani heat shock protein 100: characterization and func-
Bifeld et al.
November/December 2018 Volume 3 Issue 6 e00214-18 msystems.asm.org 16
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
tion in amastigote stage differentiation. J Biol Chem 273:6488–6494.
https://doi.org/10.1074/jbc.273.11.6488.
34. Hombach A, Ommen G, MacDonald A, Clos J. 2014. A small heat shock
protein is essential for thermotolerance and intracellular survival of
Leishmania donovani. J Cell Sci 127:4762–4773. https://doi.org/10.1242/
jcs.157297.
35. Barak E, Amin-Spector S, Gerliak E, Goyard S, Holland N, Zilberstein D.
2005. Differentiation of Leishmania donovani in host-free system: anal-
ysis of signal perception and response. Mol Biochem Parasitol 141:
99–108. https://doi.org/10.1016/j.molbiopara.2005.02.004.
36. Hübel A, Clos J. 1996. The genomic organization of the HSP83 gene
locus is conserved in three Leishmania species. Exp Parasitol 82:225–228.
https://doi.org/10.1006/expr.1996.0029.
37. Ommen G, Chrobak M, Clos J. 2010. The co-chaperone SGT of Leishma-
nia donovani is essential for the parasite’s viability. Cell Stress Chaper-
ones 15:443–455. https://doi.org/10.1007/s12192-009-0160-7.
38. Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM. 1994.
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein com-
plex formation by benzoquinone ansamycins: essential role for stress
proteins in oncogenic transformation. Proc Natl Acad Sci U S A 91:
8324–8328. https://doi.org/10.1073/pnas.91.18.8324.
39. Prodromou C, Nuttall JM, Millson SH, Roe SM, Sim TS, Tan D, Workman
P, Pearl LH, Piper PW. 2009. Structural basis of the radicicol resistance
displayed by a fungal hsp90. ACS Chem Biol 4:289–297. https://doi.org/
10.1021/cb9000316.
40. Descoteaux A, Avila HA, Zhang K, Turco SJ, Beverley SM. 2002. Leishma-
nia LPG3 encodes a GRP94 homolog required for phosphoglycan syn-
thesis implicated in parasite virulence but not viability. EMBO J 21:
4458–4469. https://doi.org/10.1093/emboj/cdf447.
41. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. 1995. Identiﬁcation
of a protein with homology to hsp90 that binds the type 1 tumor
necrosis factor receptor. J Biol Chem 270:3574–3581. https://doi.org/10
.1074/jbc.270.8.3574.
42. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I, Lynn MA,
McMaster WR, Foster LJ, Levings MK, Reiner NE. 2010. Leishmania exo-
somes modulate innate and adaptive immune responses through effects
on monocytes and dendritic cells. J Immunol 185:5011–5022. https://doi
.org/10.4049/jimmunol.1000541.
43. Paape D, Barrios-Llerena ME, Le Bihan T, Mackay L, Aebischer T. 2010.
Gel free analysis of the proteome of intracellular Leishmania mexi-
cana. Mol Biochem Parasitol 169:108–114. https://doi.org/10.1016/j
.molbiopara.2009.10.009.
44. Galas DJ, Schmitz A. 1978. DNAse footprinting: a simple method for the
detection of protein-DNA binding speciﬁcity. Nucleic Acids Res
5:3157–3170. https://doi.org/10.1093/nar/5.9.3157.
45. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. 2009.
Genome-wide analysis in vivo of translation with nucleotide resolu-
tion using ribosome proﬁling. Science 324:218–223. https://doi.org/
10.1126/science.1168978.
46. Morris DR, Geballe AP. 2000. Upstream open reading frames as regula-
tors of mRNA translation. Mol Cell Biol 20:8635–8642. https://doi.org/10
.1128/MCB.20.23.8635-8642.2000.
47. Meijer HA, Thomas AA. 2002. Control of eukaryotic protein synthesis by
upstream open reading frames in the 5=-untranslated region of an
mRNA. Biochem J 367:1–11. https://doi.org/10.1042/BJ20011706.
48. Smircich P, Eastman G, Bispo S, Duhagon MA, Guerra-Slompo EP, Garat
B, Goldenberg S, Munroe DJ, Dallagiovanna B, Holetz F, Sotelo-Silveira
JR. 2015. Ribosome proﬁling reveals translation control as a key mech-
anism generating differential gene expression in Trypanosoma cruzi.
BMC Genomics 16:443. https://doi.org/10.1186/s12864-015-1563-8.
49. Jensen BC, Ramasamy G, Vasconcelos EJ, Ingolia NT, Myler PJ, Parsons M.
2014. Extensive stage-regulation of translation revealed by ribosome
proﬁling of Trypanosoma brucei. BMC Genomics 15:911. https://doi.org/
10.1186/1471-2164-15-911.
50. Vasquez JJ, Hon CC, Vanselow JT, Schlosser A, Siegel TN. 2014. Compar-
ative ribosome proﬁling reveals extensive translational complexity in
different Trypanosoma brucei life cycle stages. Nucleic Acids Res 42:
3623–3637. https://doi.org/10.1093/nar/gkt1386.
51. Hassan MA, Vasquez JJ, Guo-Liang C, Meissner M, Siegel TN. 2017.
Comparative ribosome proﬁling uncovers a dominant role for transla-
tional control in Toxoplasma gondii. BMC Genomics 18:961. https://doi
.org/10.1186/s12864-017-4362-6.
52. Yoffe Y, Zuberek J, Lerer A, Lewdorowicz M, Stepinski J, Altmann M,
Darzynkiewicz E, Shapira M. 2006. Binding speciﬁcities and potential
roles of isoforms of eukaryotic initiation factor 4E in Leishmania. Eu-
karyot Cell 5:1969–1979. https://doi.org/10.1128/EC.00230-06.
53. Ingolia NT, Brar GA, Rouskin S, McGeachy AM, Weissman JS. 2012. The
ribosome proﬁling strategy for monitoring translation in vivo by deep
sequencing of ribosome-protected mRNA fragments. Nat Protoc
7:1534–1550. https://doi.org/10.1038/nprot.2012.086.
54. Calviello L, Mukherjee N, Wyler E, Zauber H, Hirsekorn A, Selbach M,
Landthaler M, Obermayer B, Ohler U. 2016. Detecting actively translated
open reading frames in ribosome proﬁling data. Nat Methods 13:
165–170. https://doi.org/10.1038/nmeth.3688.
55. Calvo SE, Pagliarini DJ, Mootha VK. 2009. Upstream open reading frames
cause widespread reduction of protein expression and are polymorphic
among humans. Proc Natl Acad Sci U S A 106:7507–7512. https://doi
.org/10.1073/pnas.0810916106.
56. Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation
in eukaryotes: mechanisms and biological targets. Cell 136:731–745.
https://doi.org/10.1016/j.cell.2009.01.042.
57. Barbosa C, Peixeiro I, Romao L. 2013. Gene expression regulation by
upstream open reading frames and human disease. PLoS Genet
9:e1003529. https://doi.org/10.1371/journal.pgen.1003529.
58. Wiesgigl M, Clos J. 1999. Uniform distribution of transcription complexes
on the clpB gene locus of Leishmania donovani. Protist 150:369–373.
https://doi.org/10.1016/S1434-4610(99)70038-6.
59. Freire ER, Dhalia R, Moura DM, da Costa Lima TD, Lima RP, Reis CR,
Hughes K, Figueiredo RC, Standart N, Carrington M, de Melo Neto OP.
2011. The four trypanosomatid eIF4E homologues fall into two sep-
arate groups, with distinct features in primary sequence and biolog-
ical properties. Mol Biochem Parasitol 176:25–36. https://doi.org/10
.1016/j.molbiopara.2010.11.011.
60. McCall LI, Matlashewski G. 2012. Involvement of the Leishmania
donovani virulence factor A2 in protection against heat and oxidative
stress. Exp Parasitol 132:109–115. https://doi.org/10.1016/j.exppara
.2012.06.001.
61. Wu Y, El Fakhry Y, Sereno D, Tamar S, Papadopoulou B. 2000. A new
developmentally regulated gene family in Leishmania amastigotes en-
coding a homolog of amastin surface proteins. Mol Biochem Parasitol
110:345–357. https://doi.org/10.1016/S0166-6851(00)00290-5.
62. Kozak M. 1992. Regulation of translation in eukaryotic systems. Annu
Rev Cell Biol 8:197–225. https://doi.org/10.1146/annurev.cb.08
.110192.001213.
63. McNicoll F, Drummelsmith J, Muller M, Madore E, Boilard N, Ouellette M,
Papadopoulou B. 2006. A combined proteomic and transcriptomic ap-
proach to the study of stage differentiation in Leishmania infantum.
Proteomics 6:3567–3581. https://doi.org/10.1002/pmic.200500853.
64. Li GW, Burkhardt D, Gross C, Weissman JS. 2014. Quantifying absolute
protein synthesis rates reveals principles underlying allocation of cellular
resources. Cell 157:624–635. https://doi.org/10.1016/j.cell.2014.02.033.
65. Clayton C, Shapira M. 2007. Post-transcriptional regulation of gene
expression in trypanosomes and leishmanias. Mol Biochem Parasitol
156:93–101. https://doi.org/10.1016/j.molbiopara.2007.07.007.
66. Hinnebusch AG. 2011. Molecular mechanism of scanning and start
codon selection in eukaryotes. Microbiol Mol Biol Rev 75:434–467.
https://doi.org/10.1128/MMBR.00008-11.
67. Vagner S, Galy B, Pyronnet S. 2001. Irresistible IRES. Attracting the
translation machinery to internal ribosome entry sites. EMBO Rep
2:893–898. https://doi.org/10.1093/embo-reports/kve208.
68. David M, Gabdank I, Ben-David M, Zilka A, Orr I, Barash D, Shapira M.
2010. Preferential translation of Hsp83 in Leishmania requires a
thermosensitive polypyrimidine-rich element in the 3’ UTR and in-
volves scanning of the 5’ UTR. RNA 16:364–374. https://doi.org/10
.1261/rna.1874710.
69. Fiebig M, Kelly S, Gluenz E. 2015. Comparative life cycle transcriptomics
revises Leishmania mexicana genome annotation and links a chromo-
some duplication with parasitism of vertebrates. PLoS Pathog 11:
e1005186. https://doi.org/10.1371/journal.ppat.1005186.
70. Spriggs KA, Bushell M, Willis AE. 2010. Translational regulation of gene
expression during conditions of cell stress. Mol Cell 40:228–237. https://
doi.org/10.1016/j.molcel.2010.09.028.
71. Ingolia NT, Lareau LF, Weissman JS. 2011. Ribosome proﬁling of mouse
embryonic stem cells reveals the complexity and dynamics of mamma-
lian proteomes. Cell 147:789–802. https://doi.org/10.1016/j.cell.2011.10
.002.
72. Lee S, Liu B, Lee S, Huang SX, Shen B, Qian SB. 2012. Global mapping of
translation initiation sites in mammalian cells at single-nucleotide reso-
Radicicol-Induced Proteins in Leishmania
November/December 2018 Volume 3 Issue 6 e00214-18 msystems.asm.org 17
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
lution. Proc Natl Acad Sci U S A 109:E2424–E2432. https://doi.org/10
.1073/pnas.1207846109.
73. Hinnebusch AG. 2005. Translational regulation of GCN4 and the general
amino acid control of yeast. Annu Rev Microbiol 59:407–450. https://doi
.org/10.1146/annurev.micro.59.031805.133833.
74. Starck SR, Tsai JC, Chen K, Shodiya M, Wang L, Yahiro K, Martins-Green
M, Shastri N, Walter P. 2016. Translation from the 5’ untranslated region
shapes the integrated stress response. Science 351:aad3867. https://doi
.org/10.1126/science.aad3867.
75. Bente M, Harder S, Wiesgigl M, Heukeshoven J, Gelhaus C, Krause E, Clos
J, Bruchhaus I. 2003. Developmentally induced changes of the proteome
in the protozoan parasite Leishmania donovani. Proteomics
3:1811–1829. https://doi.org/10.1002/pmic.200300462.
76. Petersen AL, Guedes CE, Versoza CL, Lima JG, de Freitas LA, Borges VM,
Veras PS. 2012. 17-AAG kills intracellular Leishmania amazonensis while
reducing inﬂammatory responses in infected macrophages. PLoS One
7:e49496. https://doi.org/10.1371/journal.pone.0049496.
77. Santos DM, Petersen AL, Celes FS, Borges VM, Veras PS, de Oliveira CI.
2014. Chemotherapeutic potential of 17-AAG against cutaneous leish-
maniasis caused by Leishmania (Viannia) braziliensis. PLoS Negl Trop Dis
8:e3275. https://doi.org/10.1371/journal.pntd.0003275.
78. Schulte TW, Akinaga S, Murakata T, Agatsuma T, Sugimoto S, Nakano H,
Lee YS, Simen BB, Argon Y, Felts S, Toft DO, Neckers LM, Sharma SV.
1999. Interaction of radicicol with members of the heat shock protein 90
family of molecular chaperones. Mol Endocrinol 13:1435–1448. https://
doi.org/10.1210/mend.13.9.0339.
79. Ryan KA, Garraway LA, Descoteaux A, Turco SJ, Beverley SM. 1993.
Iso lat ion of v i ru lence genes direct ing surface glycosyl -
phosphatidylinositol synthesis by functional complementation of Leish-
mania. Proc Natl Acad Sci U S A 90:8609–8613. https://doi.org/10.1073/
pnas.90.18.8609.
80. Immormino RM, Dollins DE, Shaffer PL, Soldano KL, Walker MA, Gewirth
DT. 2004. Ligand-induced conformational shift in the N-terminal domain
of GRP94, an Hsp90 chaperone. J Biol Chem 279:46162–46171. https://
doi.org/10.1074/jbc.M405253200.
81. Frey S, Leskovar A, Reinstein J, Buchner J. 2007. The ATPase cycle of the
endoplasmic chaperone Grp94. J Biol Chem 282:35612–35620. https://
doi.org/10.1074/jbc.M704647200.
82. Dolai S, Yadav RK, Pal S, Adak S. 2009. Overexpression of mitochondrial
Leishmania major ascorbate peroxidase enhances tolerance to oxidative
stress-induced programmed cell death and protein damage. Eukaryot
Cell 8:1721–1731. https://doi.org/10.1128/EC.00198-09.
83. Haimeur A, Brochu C, Genest P, Papadopoulou B, Ouellette M. 2000.
Ampliﬁcation of the ABC transporter gene PGPA and increased trypano-
thione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania
tarentolae. Mol Biochem Parasitol 108:131–135. https://doi.org/10.1016/
S0166-6851(00)00187-0.
84. Colotti G, Ilari A. 2011. Polyamine metabolism in Leishmania: from
arginine to trypanothione. Amino Acids 40:269–285. https://doi.org/10
.1007/s00726-010-0630-3.
85. Salotra P, Duncan RC, Singh R, Subba Raju BV, Sreenivas G, Nakhasi HL.
2006. Upregulation of surface proteins in Leishmania donovani isolated
from patients of post kala-azar dermal leishmaniasis. Microbes Infect
8:637–644. https://doi.org/10.1016/j.micinf.2005.08.018.
86. de Paiva RM, Grazielle-Silva V, Cardoso MS, Nakagaki BN, Mendonca-
Neto RP, Canavaci AM, Souza Melo N, Martinelli PM, Fernandes AP,
daRocha WD, Teixeira SM. 2015. Amastin knockdown in Leishmania
braziliensis affects parasite-macrophage interaction and results in im-
paired viability of intracellular amastigotes. PLoS Pathog 11:e1005296.
https://doi.org/10.1371/journal.ppat.1005296.
87. Morales M, Watanabe R, Dacher M, Chafey P, Osorio y Fortéa J, Beverley
S, Ommen G, Clos J, Hem S, Lenormand P, Rousselle J-C, Namane A,
Spath G. 2010. Phosphoproteome dynamics reveals heat shock protein
complexes speciﬁc to the Leishmania infectious stage. Proc Natl Acad Sci
U S A 107:8381–8386. https://doi.org/10.1073/pnas.0914768107.
88. Kaur P, Garg M, Hombach-Barrigah A, Clos J, Goyal N. 2017. MAPK1 of
Leishmania donovani interacts and phosphorylates HSP70 and HSP90
subunits of foldosome complex. Sci Rep 7:10202. https://doi.org/10
.1038/s41598-017-09725-w.
89. Wiese M. 1998. A mitogen-activated protein (MAP) kinase homologue of
Leishmania mexicana is essential for parasite survival in the infected
host. EMBO J 17:2619–2628. https://doi.org/10.1093/emboj/17.9.2619.
90. Rachidi N, Taly JF, Durieu E, Leclercq O, Aulner N, Prina E, Pescher P,
Notredame C, Meijer L, Spath GF. 2014. Pharmacological assessment
deﬁnes Leishmania donovani casein kinase 1 as a drug target and
reveals important functions in parasite viability and intracellular infec-
tion. Antimicrob Agents Chemother 58:1501–1515. https://doi.org/10
.1128/AAC.02022-13.
91. Durieu E, Prina E, Leclercq O, Oumata N, Gaboriaud-Kolar N, Vougogi-
annopoulou K, Aulner N, Defontaine A, No JH, Ruchaud S, Skaltsounis AL,
Galons H, Spath GF, Meijer L, Rachidi N. 2016. From drug screening to
target deconvolution: a target-based drug discovery pipeline using
Leishmania casein kinase 1 isoform 2 to identify compounds with anti-
leishmanial activity. Antimicrob Agents Chemother 60:2822–2833.
https://doi.org/10.1128/AAC.00021-16.
92. Allocco JJ, Donald R, Zhong T, Lee A, Tang YS, Hendrickson RC, Liberator
P, Nare B. 2006. Inhibitors of casein kinase 1 block the growth of
Leishmania major promastigotes in vitro. Int J Parasitol 36:1249–1259.
https://doi.org/10.1016/j.ijpara.2006.06.013.
93. Silverman JM, Clos J, de’Oliveira CC, Shirvani O, Fang Y, Wang C, Foster
LJ, Reiner NE. 2010. An exosome-based secretion pathway is responsible
for protein export from Leishmania and communication with macro-
phages. J Cell Sci 123:842–852. https://doi.org/10.1242/jcs.056465.
94. Ingolia NT. 2010. Genome-wide translational proﬁling by ribosome foot-
printing. Methods Enzymol 470:119–142. https://doi.org/10.1016/S0076
-6879(10)70006-9.
95. Martin M. 2011. Cutadapt removes adapter sequences from high-
throughput sequencing reads. EMBnet J 17:10–12. https://doi.org/10
.14806/ej.17.1.200.
96. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and
memory-efﬁcient alignment of short DNA sequences to the human
genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25.
97. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P,
Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner.
Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635.
98. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G,
Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup.
2009. The Sequence Alignment/Map format and SAMtools. Bioinformat-
ics 25:2078–2079. https://doi.org/10.1093/bioinformatics/btp352.
Bifeld et al.
November/December 2018 Volume 3 Issue 6 e00214-18 msystems.asm.org 18
 o
n
 N
ovem
ber 21, 2019 by guest
http://m
system
s.asm
.org/
D
ow
nloaded from
 
